FutureFuel shares rally on big profit jump 4:20 p.m. March 17, 2014 - Wallace Witkowski
3 best hedge fund managers of 2013 1:50 p.m. Jan. 22, 2014 - Insider Monkey
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
First patient dosed in NeuVax Phase 2 breast cancer trial 12:04 p.m. Nov. 11, 2014 - Seeking Alpha
10-Q: GALENA BIOPHARMA, INC. 4:40 p.m. Nov. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Monday’s close 5:35 p.m. Nov. 2, 2014 - Seeking Alpha
Galena gets NOA for NeuVax patent app in Japan 11:59 a.m. Oct. 14, 2014 - Seeking Alpha
FDA clears Akynzeo for chemo-induced nausea and vomiting 9:50 a.m. Oct. 10, 2014 - Seeking Alpha
Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape 8:00 a.m. Oct. 9, 2014 - Zacks.com
Three Lessons From The Galena Scandal 10:02 a.m. Aug. 21, 2014 - Seeking Alpha
Galena Biopharma (GALE) Replaces CEO Mark Ahn 9:10 a.m. Aug. 21, 2014 - InvestorPlace.com
Galena CEO gets the boot 6:33 a.m. Aug. 21, 2014 - Seeking Alpha
Galena CEO Fired Following Stock-Promotions Scandal 6:16 a.m. Aug. 21, 2014 - TheStreet.com
Biotech Stock Mailbag: Exact Sciences, Galena, Amgen 6:22 a.m. Aug. 15, 2014 - TheStreet.com
Galena Biopharma's (GALE) CEO Mark Ahn on Q2 2014 Results - Earnings Call Transcript 8:17 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: GALENA BIOPHARMA, INC. 4:19 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
20 Cheap Stocks Under $10 Worth Zilch 4:40 a.m. Aug. 5, 2014 - InvestorPlace.com
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 4:22 p.m. Aug. 4, 2014 - Seeking Alpha
Galectin Pays Stock Promoters to Entice Retail Investors 11:34 a.m. July 28, 2014 - TheStreet.com
Galena Gives Sales Team Another Useless Product to Promote 8:41 a.m. July 22, 2014 - TheStreet.com
Galena secures U.S. rights to serotonin blocker 7:33 a.m. July 22, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 10:11 a.m. July 8, 2014 - Barrons.com
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 8:49 a.m. July 2, 2014 - TheStreet.com
Galena Biopharma to Present at the Stifel 2014 Healthcare Conference 7:06 a.m. Nov. 13, 2014 - GlobeNewswire
Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients 7:06 a.m. Nov. 11, 2014 - GlobeNewswire
Galena Biopharma Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial Data at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting 7:06 a.m. Nov. 7, 2014 - GlobeNewswire
Galena Biopharma to Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data at the Society for the Immunotherapy of Cancer (SITC) 29th Annual Meeting on Friday, November 7, 2014 7:06 a.m. Nov. 4, 2014 - GlobeNewswire
Heat Biologics Takes a New Approach to Immunotherapy 2:01 p.m. Nov. 3, 2014 - ACCESSWIRE
The most undervalued, yet comprehensive cancer immunotherapy in development? 8:04 a.m. Nov. 3, 2014 - ACCESSWIRE
Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014 6:06 a.m. Oct. 27, 2014 - GlobeNewswire
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan 6:05 a.m. Oct. 14, 2014 - GlobeNewswire
Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination 6:06 a.m. Oct. 8, 2014 - GlobeNewswire
Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update 3:15 p.m. Sept. 25, 2014 - GlobeNewswire
Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial 6:05 a.m. Sept. 9, 2014 - GlobeNewswire
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 8:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 6:06 a.m. Sept. 3, 2014 - GlobeNewswire
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer 6:05 a.m. Aug. 21, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 6:06 a.m. July 29, 2014 - GlobeNewswire
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film 6:16 a.m. July 22, 2014 - GlobeNewswire
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film 6:06 a.m. July 22, 2014 - GlobeNewswire
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 4:30 a.m. July 4, 2014 - PR Newswire - PRF